Not currently recruiting at UC Health
RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation
a study on Graft Versus Host Disease Hematopoietic Cell Transplantation
Summary
- Eligibility
- for people ages 18-64 (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Regimmune Corporation
- ID
- NCT04014790
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated